145 related articles for article (PubMed ID: 25200244)
1. Clinical characteristics of breast cancers in African-American women with benign breast disease: a comparison to the surveillance, epidemiology, and end results program.
Mitro SD; Ali-Fehmi R; Bandyopadhyay S; Alosh B; Albashiti B; Radisky DC; Frost MH; Degnim AC; Ruterbusch JJ; Cote ML
Breast J; 2014; 20(6):571-7. PubMed ID: 25200244
[TBL] [Abstract][Full Text] [Related]
2. Association Between Benign Breast Disease in African American and White American Women and Subsequent Triple-Negative Breast Cancer.
Newman LA; Stark A; Chitale D; Pepe M; Longton G; Worsham MJ; Nathanson SD; Miller P; Bensenhaver JM; Proctor E; Swain M; Patriotis C; Engstrom PF
JAMA Oncol; 2017 Aug; 3(8):1102-1106. PubMed ID: 28006062
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer incidence in a cohort of women with benign breast disease from a multiethnic, primary health care population.
Worsham MJ; Abrams J; Raju U; Kapke A; Lu M; Cheng J; Mott D; Wolman SR
Breast J; 2007; 13(2):115-21. PubMed ID: 17319851
[TBL] [Abstract][Full Text] [Related]
4. Benign breast disease and the risk of subsequent breast cancer in African American women.
Cote ML; Ruterbusch JJ; Alosh B; Bandyopadhyay S; Kim E; Albashiti B; Sharaf Aldeen B; Radisky DC; Frost MH; Visscher DW; Hartmann LC; Nassar WH; Ali-Femhi R
Cancer Prev Res (Phila); 2012 Dec; 5(12):1375-80. PubMed ID: 23087047
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for breast cancer from benign breast disease in a diverse population.
Worsham MJ; Raju U; Lu M; Kapke A; Botttrell A; Cheng J; Shah V; Savera A; Wolman SR
Breast Cancer Res Treat; 2009 Nov; 118(1):1-7. PubMed ID: 18836828
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for breast cancer development by tumor characteristics among women with benign breast disease.
Figueroa JD; Gierach GL; Duggan MA; Fan S; Pfeiffer RM; Wang Y; Falk RT; Loudig O; Abubakar M; Ginsberg M; Kimes TM; Richert-Boe K; Glass AG; Rohan TE
Breast Cancer Res; 2021 Mar; 23(1):34. PubMed ID: 33736682
[TBL] [Abstract][Full Text] [Related]
7. Breast Density and Benign Breast Disease: Risk Assessment to Identify Women at High Risk of Breast Cancer.
Tice JA; Miglioretti DL; Li CS; Vachon CM; Gard CC; Kerlikowske K
J Clin Oncol; 2015 Oct; 33(28):3137-43. PubMed ID: 26282663
[TBL] [Abstract][Full Text] [Related]
8. Clinical and histologic characteristics of breast cancers in women with previous pathologic diagnosis of benign breast disease in Spain.
Román M; Caicoya M; Espinàs J; Sala M; Torá-Rocamora I; Quinta MJ; Vernet M; Saladié F; Romero A; Sánchez M; Baré M; Vidal C; Servitja S; Natal C; Corominas J; Ferrer J; Rodríguez-Arana A; Castells X;
Breast J; 2018 Jul; 24(4):509-518. PubMed ID: 29517151
[TBL] [Abstract][Full Text] [Related]
9. Benign Breast Disease and Breast Cancer Risk in the Percutaneous Biopsy Era.
Sherman ME; Vierkant RA; Winham SJ; Vachon CM; Carter JM; Pacheco-Spann L; Jensen MR; McCauley BM; Hoskin TL; Seymour L; Gehling D; Fischer J; Ghosh K; Radisky DC; Degnim AC
JAMA Surg; 2024 Feb; 159(2):193-201. PubMed ID: 38091020
[TBL] [Abstract][Full Text] [Related]
10. Multiplicity of benign breast disease lesions and breast cancer risk in African American women.
Patil V; Ruterbusch JJ; Chen W; Boerner JL; Abdulfatah E; Alosh B; Pardeshi V; Shaik AN; Bandyopadhyay S; Ali-Fehmi R; Cote ML
Front Oncol; 2024; 14():1410819. PubMed ID: 38817898
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of 2 breast cancer risk models in a benign breast disease cohort.
Frank RD; Winham SJ; Vierkant RA; Frost MH; Radisky DC; Ghosh K; Brandt KR; Sherman ME; Visscher DW; Hartmann LC; Degnim AC; Vachon CM
Cancer; 2018 Aug; 124(16):3319-3328. PubMed ID: 29932456
[TBL] [Abstract][Full Text] [Related]
12. Association between lifestyle, menstrual/reproductive history, and histological factors and risk of breast cancer in women biopsied for benign breast disease.
Arthur R; Wang Y; Ye K; Glass AG; Ginsberg M; Loudig O; Rohan T
Breast Cancer Res Treat; 2017 Oct; 165(3):623-631. PubMed ID: 28643020
[TBL] [Abstract][Full Text] [Related]
13. Inflammation markers on benign breast biopsy are associated with risk of invasive breast cancer in African American women.
Shaik AN; Kiavash K; Stark K; Boerner JL; Ruterbusch JJ; Deirawan H; Bandyopadhyay S; Ali-Fehmi R; Dyson G; Cote ML
Breast Cancer Res Treat; 2021 Feb; 185(3):831-839. PubMed ID: 33113091
[TBL] [Abstract][Full Text] [Related]
14. Racial differences in survival of female breast cancer in the Detroit metropolitan area.
Simon MS; Severson RK
Cancer; 1996 Jan; 77(2):308-14. PubMed ID: 8625239
[TBL] [Abstract][Full Text] [Related]
15. Benign breast disease heterogeneity: association with histopathology, age, and ethnicity.
Cheng J; Qiu S; Raju U; Wolman SR; Worsham MJ
Breast Cancer Res Treat; 2008 Sep; 111(2):289-96. PubMed ID: 17917807
[TBL] [Abstract][Full Text] [Related]
16. Lower-category benign breast disease and the risk of invasive breast cancer.
Wang J; Costantino JP; Tan-Chiu E; Wickerham DL; Paik S; Wolmark N
J Natl Cancer Inst; 2004 Apr; 96(8):616-20. PubMed ID: 15100339
[TBL] [Abstract][Full Text] [Related]
17. Infiltrating immune cells in benign breast disease and risk of subsequent invasive breast cancer.
Rohan TE; Arthur R; Wang Y; Weinmann S; Ginsberg M; Loi S; Salgado R
Breast Cancer Res; 2021 Jan; 23(1):15. PubMed ID: 33516237
[TBL] [Abstract][Full Text] [Related]
18. Impact of breast carcinoma on African-American women: the Detroit experience.
Newman LA; Carolin K; Simon M; Kosir M; Hyrniuk W; Demers R; Grossbart Schwartz A; Visscher D; Peters W; Bouwman D
Cancer; 2001 May; 91(9):1834-43. PubMed ID: 11335911
[TBL] [Abstract][Full Text] [Related]
19. Multiplicity of benign breast lesions is a risk factor for progression to breast cancer.
Worsham MJ; Raju U; Lu M; Kapke A; Cheng J; Wolman SR
Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5474-9. PubMed ID: 17875777
[TBL] [Abstract][Full Text] [Related]
20. Benign Breast Disease, NSAIDs, and Postmenopausal Breast Cancer Risk in the CPS-II Cohort.
Sherman ME; Vierkant RA; Masters M; Radisky DC; Winham SJ; Degnim AC; Vachon CM; Patel AV; Teras LR
Cancer Prev Res (Phila); 2023 Mar; 16(3):175-184. PubMed ID: 36596665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
